Industry: Peptides and Proteins
Headquarters: Geneva, Geneve, Switzerland
Founded Date: 2012-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 9
Total Funding: 45336548
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-11-12
Last Funding Type: Series B

Visit Website
contact@amaltherapeutics.com
https://twitter.com/ArrowheadPharma
Register and Claim Ownership